UroLift Preserves Sexual Function in Benign Prostatic Hyperplasia (BPH) Patients
the Renal and Urology News take:
A new device offers minimally-invasive treatment of benign prostatic hyperplasia (BPH) without risk of sexual dysfunction, according to a release.
“The device reshapes the anterior prostatic urethra creating a channel by tensioned monofilament sutures placed under cystoscopic guidance,” researchers noted. “Sutures are anchored with a metallic tab on the prostate capsule and then tensioned on the luminal aspect to compress the prostate. This has been shown to achieve a rapid and sustained improvement in flow rate and symptom score in follow-up studies.”
In the randomized controlled study published in the British Journal of Urology International, the researchers looked at 206 patients who were evaluated for BPH. They found that the UroLift system improved symptoms, quality of life and urinary flow for two years, with 7.5% requiring additional BPH procedures.
In addition, not a single patient has been successful in preserving sexual function, compared to 65% of men who had lost the ability to ejaculate after having undergone standard transurethral resection of the prostate (TURP) surgery.
“This system seems to offer an excellent minimally invasive method to treat LUTS, while preserving sexual function,” the researchers concluded.
UroLift offers minimally-invasive treatment of benign prostatic hyperplasia without risk of sexual dysfunction.
NeoTract, Inc., today welcomes the publication of a paper in the British Journal of Urology International which calls for men suffering from enlarged prostate to discuss with their doctors the likely impact of treatment options on their sexual function. Most procedures and many medications can cause sexual dysfunction.
Clinical studies show that treatment with the UroLift® system has not been associated with any new onset of sustained ejaculatory or erectile dysfunction. BPH, benign prostatic hyperplasia, enlarges the prostate, which can lead to lower urinary tract symptoms (LUTS) that can cause serious quality of life issues such as interrupted sleep, urgent and frequent need to urinate, depression and isolation.
Renal and Urology News Articles
- Researchers Identify mCRPC Drug Sequence Offering the Best Survival
- Novel Calcimimetic Approved for Secondary Hyperparathyroidism
- Prostate Cancer Treatment Prolongs Survival
- Misplaced Mobile Devices Lead to HHS Investigations, Millions in Fines
- PCa Salvage Radiation Plus Anti-Androgen Therapy Improves Outcomes
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)